Valuation: DECHRA PHARMACEUTICALS LIMITED

Market Cap 4.4B 5.77B 5.26B 4.87B 8.26B 539B 8.65B 58.85B 23.34B 291B 21.66B 21.2B 923B P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 4.83B 6.34B 5.77B 5.34B 9.07B 592B 9.49B 64.59B 25.62B 320B 23.77B 23.27B 1,013B EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
Manager TitleAgeSince
Chief Executive Officer - 2024-06-09
Director of Finance/CFO 46 2019-04-02
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 2019-10-29
Director/Board Member 68 2016-11-30
Director/Board Member 59 2019-01-31

Financials

2022 2023
Net sales 682M 894M 814M 754M 1.28B 83.47B 1.34B 9.11B 3.61B 45.1B 3.35B 3.28B 143B 762M 998M 909M 842M 1.43B 93.22B 1.5B 10.18B 4.04B 50.38B 3.74B 3.67B 160B
Net income 58.2M 76.29M 69.51M 64.34M 109M 7.12B 114M 778M 309M 3.85B 286M 280M 12.2B -27.9M -36.57M -33.32M -30.84M -52.34M -3.42B -54.78M -373M -148M -1.85B -137M -134M -5.85B
Net Debt 208M 273M 249M 230M 391M 25.49B 409M 2.78B 1.1B 13.77B 1.02B 1B 43.63B 430M 564M 514M 475M 807M 52.65B 844M 5.75B 2.28B 28.45B 2.12B 2.07B 90.13B
Logo DECHRA PHARMACEUTICALS LIMITED
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-